Sign Up

GSK’s $10.6bn cancer deal will lead to more

Financial Times 1 min read 16 hours ago

Making additional moves would be in keeping with pharma group’s strategy of building its pipeline as fast as possible
Read original Financial Times

More from Financial Times

GM bets on homegrown battery tech to challenge Chinese dominance
Apollo hunts for Japanese life insurer to boost growth
Why are investors so jumpy?
Oil slides as US official says Hormuz transits are ‘meaningfully’ climbing

Related in Business

GM bets on homegrown battery tech to challenge Chinese dominance
Apollo hunts for Japanese life insurer to boost growth
Why are investors so jumpy?
Oil slides as US official says Hormuz transits are ‘meaningfully’ climbing